Using contrast-enhanced ultrasound to better understand unclear liver lesions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of contrast-enhanced ultrasound (CEUS) in accurately characterizing focal liver lesions that have been inconclusive through CT, MRI, or PET scans. It will involve both retrospective and prospective data collection, with a follow-up period of six months to assess outcomes based on the gold standard reference. The study will include patients who have undergone CEUS within the last six months and will analyze the results to determine whether the lesions are benign or malignant.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years.
* CEUS performed performed in the last 6 months a CT, MRI and/or PET not decisive in characterizing a liver lesion.
* Obtaining informed consent.

Exclusion Criteria:

* Technical impossibility to perform the ultrasound evaluation.
* Documented allergy to the ultrasound contrast medium.

Where it's running

• Policlinico Sant'Orsola Malpighi
  Bologna, Italy Recruiting

Study contacts

• Principal investigator: Carla Serra, PhD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Carla Serra, PhD
• Email: carla.serra@aosp.bo.it
• Phone: +390512143270

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Risk factors for outcomes after surgery for very large intrathoracic tumors

  This study tests how patients with very large chest tumors fare after surgical removal, to see which factors are linked to better or worse outcomes.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT07926490

• IBS and rosacea in adults: how common is rosacea among people with IBS at a university center

  This observational study tests how often rosacea occurs in adults with IBS who are treated at a university hospital in Bologna.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Italy · NCT07922668

• INSL3 as a Biomarker to See If Puberty Has Started

  Researchers are testing whether a single blood test for INSL3 can tell if a child’s puberty has begun, potentially reducing need for the GnRH stimulation test.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT07859787

• Ultrasound-guided pelvic floor training to help birth in first-time pregnant women

  This study tests if real-time ultrasound feedback on pelvic floor muscles during labor preparation helps shorten the second stage of labor in first-time pregnant women with specific pelvic floor muscle activation.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT07675642

• Rail Biopsy vs Chip Biopsy for endometrial sampling in women with atrophic or hypotrophic endometrium

  This study compares how long it takes to perform rail biopsy versus chip biopsy in menopausal- age women needing an endometrial biopsy.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT07675317

• Cardiac and carotid ultrasound reference values in healthy children in Italy

  This study tests heart and artery measurements to establish normal reference values for healthy kids in Italy.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bologna · NCT07666451

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.